A Study of Live Tumor Fragments of Surgical Resections
Launched by MAYO CLINIC · May 23, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how tumor tissue, which is removed during cancer surgery, can be used to learn more about how tumors behave and respond to treatment. The goal is to collect unused pieces of this tumor tissue and the related health information from patients to study how the tumor environment works and how effective different treatments might be. By analyzing these samples in a special way, researchers hope to gain insights that could help improve cancer treatments in the future.
To participate in this study, you need to be planning to have surgery to remove your cancer and be able to understand and sign a consent form agreeing to the research. Unfortunately, if there isn't any leftover tissue for research when your surgery is done, you won't be able to take part. This trial is currently not recruiting participants yet, but it will be open to patients of all genders, aged 65 and older. If you join, you can expect to contribute to important research that may help other cancer patients down the line.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ability to understand and sign informed consent
- • Planning to undergo a surgical procedure to remove cancer
- Exclusion Criteria:
- • Does not meet Inclusion criteria
- • No tissue for research available at time of surgery
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jacksonville, Florida, United States
Patients applied
Trial Officials
Debabrata Mukhopadhyay, PhD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported